{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:42:42Z","timestamp":1791358962060,"version":"4.3.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jns.2021.117420","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:02:02Z","timestamp":1616846522000},"page":"117420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["The neurology of IGG4-related disease"],"prefix":"10.1016","volume":"424","author":[{"given":"G.","family":"Saitakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.K.","family":"Chwalisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117420_bb0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF02232341","article-title":"Chronic inflammatory sclerosis of the pancreas \u2013 An autonomous pancreatic disease?","volume":"6","author":"Sarles","year":"1961","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.jns.2021.117420_bb0010","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","article-title":"Autoimmune pancreatitis is a systemic autoimmune disease","volume":"98","author":"Kamisawa","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jns.2021.117420_bb0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematologica"},{"issue":"5844","key":"10.1016\/j.jns.2021.117420_bb0025","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jns.2021.117420_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12016-018-8679-y","article-title":"The immunologic paradoxes of IgG4-related disease","volume":"54","author":"Xiao","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0040","first-page":"728","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","volume":"67","author":"Hubers","year":"2018","journal-title":"Gut."},{"issue":"2","key":"10.1016\/j.jns.2021.117420_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2018.05.011","article-title":"Identification of galectin-3 as an autoantigen in patients with IgG4-related disease","volume":"143","author":"Perugino","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jns.2021.117420_bb0050","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/art.40168","article-title":"Emerging treatment models in rheumatology: IgG4-related disease: insights into human immunology and targeted therapies","volume":"69","author":"Perugino","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117420_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccm.2019.05.005","article-title":"Immunoglobulin G4-related disease","volume":"40","author":"Wallace","year":"2019","journal-title":"Clin. Chest Med."},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0065","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2018.06.082","article-title":"Gastrointestinal and extra-intestinal manifestations of IgG4 related disease","volume":"155","author":"Miyabe","year":"2018","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.jns.2021.117420_bb0070","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/rheumatology\/key397","article-title":"Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2021.117420_bb0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0080","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2021.117420_bb0085","article-title":"IgG4-related diseases: state of the art on clinical practice guidelines","volume":"4","author":"Iaccarino","year":"2019","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.jns.2021.117420_bb0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.anorl.2018.02.002","article-title":"A solely ear-involved IgG4-related sclerosing disease with two-years following-up","volume":"136","author":"Cheng","year":"2019","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"10.1016\/j.jns.2021.117420_bb0095","article-title":"An overlapping case of IgG4-related disease and systemic lupus erythematosus","volume":"7","author":"Naramala","year":"2019","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"10.1016\/j.jns.2021.117420_bb0100","series-title":"IgG4 Related Disease (IgG4-RD). StatPearls [Internet]","author":"Nambiar","year":"2019"},{"issue":"8","key":"10.1016\/j.jns.2021.117420_bb0105","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00405-018-5013-5","article-title":"IgG4-related disease: association between chronic rhino-sinusitis and systemic symptoms","volume":"275","author":"Gao","year":"2018","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jns.2021.117420_bb0110","first-page":"1","article-title":"Clinical and biochemical characteristics of patients having general symptoms with increased serum IgG4","volume":"1","author":"Hasegawa","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jns.2021.117420_bb0115","article-title":"Intrathoracic manifestations of IgG4-related disease: findings in a cohort study from North America","volume":"68","author":"Lim","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.American College of Rheumatology\/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cyt.12641","article-title":"Clinicopathological features of immunoglobulin G4-related pleural lesions and diagnostic utility of pleural effusion cytology","volume":"30","author":"Kasashima","year":"2019","journal-title":"Cytopathology."},{"key":"10.1016\/j.jns.2021.117420_bb0135","article-title":"Cutaneous manifestation of IgG4-related disease mimicking dermatitis artefacta","author":"Ashoka Menon","year":"2019","journal-title":"Australas. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/14397595.2016.1233929","article-title":"A case of alopecia as IgG4-related skin disease","volume":"29","author":"Ikeda","year":"2019","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.jns.2021.117420_bb0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.2018.16665","article-title":"Immunoglobulin G4 Levels","volume":"321","author":"Nagpal","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.jns.2021.117420_bb0150","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum IgG4 and IgG1 for distinguishing IgG4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jns.2021.117420_bb0155","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s10067-017-3685-7","article-title":"Diagnostic performance of serum IgG4 concentration and IgG4\/IgG ratio in IgG4-related disease","volume":"36","author":"Xia","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.38193","article-title":"Brief report: spuriously low IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease","volume":"66","author":"Khosroshahi","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","article-title":"Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations","volume":"74","author":"Wallace","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2021.117420_bb0170","article-title":"Evaluation of a novel serum IgG4 assay and determination of reference interval for the Japanese population","author":"Usami","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1373\/clinchem.2017.282319","article-title":"Resolution of spurious immunonephelometric IgG subclass measurement discrepancies by LC-MS\/MS","volume":"64","author":"van der Gugten","year":"2018","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0180","first-page":"157","article-title":"Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sj\u00f6gren\u2019s syndrome adults from a defined population","volume":"112","author":"Akiyama","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.jns.2021.117420_bb0185","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/annrheumdis-2017-212110","article-title":"CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease","volume":"77","author":"Akiyama","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2021.117420_bb0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10384-012-0151-6","article-title":"The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease","volume":"56","author":"Ohshima","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0195","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"19","author":"Ben Soussan","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jns.2021.117420_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.crad.2011.10.011","article-title":"Utility of FDG PET\/CT in IgG4-related systemic diseas","volume":"67","author":"Nakatani","year":"2012","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.jns.2021.117420_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"10","key":"10.1016\/j.jns.2021.117420_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"Cheuk","year":"2012","journal-title":"Semin. Diagn. Pathol."},{"issue":"11","key":"10.1016\/j.jns.2021.117420_bb0220","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.humpath.2013.05.023","article-title":"IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener\u2019s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases","volume":"44","author":"Chang","year":"2013","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.jns.2021.117420_bb0225","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/his.13787","article-title":"The histological diagnosis of IgG4-related disease on small biopsies: challenges and pitfalls","volume":"74","author":"Arora","year":"2019","journal-title":"Histopathology."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3904\/kjim.2016.304","article-title":"Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor","volume":"34","author":"Min","year":"2019","journal-title":"Korean J. Int. Med."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12880-019-0347-z","article-title":"Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease","volume":"19","author":"Li","year":"2019","journal-title":"BMC Med. Imaging"},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0240","first-page":"883","article-title":"Clinical observation of orbital IgG4-related diseases","volume":"17","author":"Wu","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.jns.2021.117420_bb0245","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s10792-018-0974-3","article-title":"The tarsal plate manifestation of IgG4-related disease","volume":"39","author":"Verhoekx","year":"2019","journal-title":"Int. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0250","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2019-000295","article-title":"The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study","volume":"4","author":"Ominato","year":"2019","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.pas.0000213445.08902.11","article-title":"Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease?","volume":"31","author":"Cheuk","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10014-015-0223-7","article-title":"IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma","volume":"32","author":"Noshiro","year":"2015","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAT.0000000000000132","article-title":"IgG4-related dacryoadenitis evolving into an extra-nodal, marginal zone B-cell lymphoma (EMZL): a tale of two lacrimal glands","volume":"46","author":"Mulay","year":"2014","journal-title":"Pathology."},{"key":"10.1016\/j.jns.2021.117420_bb0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","article-title":"Risk of malignancies in IgG4-related disease","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"7","key":"10.1016\/j.jns.2021.117420_bb0275","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jdcr.2019.05.018","article-title":"An unusual cause of bilateral orbital swelling: immunoglobulin G4-related orbital disease arising in a patient with ulcerative colitis","volume":"5","author":"Queen","year":"2019","journal-title":"JAAD Case Rep."},{"issue":"11","key":"10.1016\/j.jns.2021.117420_bb0280","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR imaging of IgG4-related disease in the head and neck and brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0285","doi-asserted-by":"crossref","DOI":"10.2500\/ar.2012.3.0026","article-title":"Locally destructive skull base lesion: IgG4-related sclerosing disease","volume":"3","author":"Alt","year":"2012","journal-title":"Allergy Rhinol. (Providence)"},{"issue":"7","key":"10.1016\/j.jns.2021.117420_bb0290","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1148\/rg.327125032","article-title":"IgG4-related disease of the head and neck: CT and MR imaging manifestations","volume":"32","author":"Fujita","year":"2012","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0295","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00330-016-4481-5","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"27","author":"Soussan","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jns.2021.117420_bb0300","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10384-012-0170-3","article-title":"Pathological findings of infraorbital nerve enlargement in IgG4-related ophthalmic disease","volume":"56","author":"Sogabe","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0305","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00417-013-2548-4","article-title":"Location and frequency of lesions in patients with IgG4-related ophthalmic diseases","volume":"252","author":"Sogabe","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0310","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/PAS.0b013e3181abdfc2","article-title":"IgG4-related sclerosing pachymeningitis","volume":"33","author":"Chan","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0315","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117420_bb0320","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","article-title":"Current approach to the diagnosis of IgG4-related disease\u2013combination of comprehensive diagnostic and organ-specific criteria","volume":"27","author":"Umehara","year":"2017","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jns.2021.117420_bb0325","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117420_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.jns.2021.117420_bb0335","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/WNL.0000000000000100","article-title":"IgG4-related leptomeningitis: a reversible cause of rapidly progressive cognitive decline","volume":"82","author":"Mehta","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117420_bb0340","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.0b013e3181f73614","article-title":"IgG4-related sclerosing pachymeningitis causing spinal cord compression","volume":"75","author":"Choi","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117420_bb0345","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3171\/2011.7.JNS1166","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma","volume":"115","author":"Kim","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.jns.2021.117420_bb0350","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaneurol.2014.40","article-title":"Central nervous system manifestation of IgG4-related disease","volume":"71","author":"Regev","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/aian.AIAN_283_18","article-title":"A series of biopsy-proven patients with immunoglobulin G4-related neurological disease","volume":"22","author":"Sireesha","year":"2019","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.jns.2021.117420_bb0360","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jns.2021.117420_bb0365","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3899\/jrheum.130678","article-title":"Cerebrospinal fluid analysis in IgG4-related hypertrophic pachymeningitis","volume":"40","author":"Della-Torre","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jns.2021.117420_bb0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jbspin.2014.01.010","article-title":"The utility of FDG-PET\/CT and other imaging techniques in the evaluation of IgG4-related disease","volume":"81","author":"Takahashi","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jns.2021.117420_bb0375","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/RLU.0000000000001153","article-title":"Utility of FDG PET\/CT for differential diagnosis of patients clinically suspected of IgG4-related disease","volume":"41","author":"Lee","year":"2016","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jns.2021.117420_bb0385","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2021.117420_bb0390","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-141-11-200412070-00033","article-title":"Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis","volume":"141","author":"van der Vliet","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2021.117420_bb0395","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11102-018-00930-y","article-title":"IgG4-related hypophysitis in patients with autoimmune pancreatitis","volume":"22","author":"Kanie","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.jns.2021.117420_bb0400","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2021.117420_bb0405","doi-asserted-by":"crossref","DOI":"10.1530\/EDM-18-0137","article-title":"Anterior hypopituitarism secondary to biopsy-proven IgG4-related hypophysitis in a young man","author":"Joshi","year":"2019","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"10.1016\/j.jns.2021.117420_bb0410","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1210\/jc.2013-1912","article-title":"Shintaro I from Japan with love: another tessera in the hypophysitis mosaic","volume":"98","author":"Patrizio","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2021.117420_bb0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/BOR.0b013e3283412f4a","article-title":"Pathogenesis of IgG4-related disease","volume":"23","author":"Zen","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2021.117420_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3457046","article-title":"Hypophyseal involvement in immunoglobulin G4-related disease: a retrospective study from a Single Tertiary Center","author":"Liu","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"9571","key":"10.1016\/j.jns.2021.117420_bb0425","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(07)60673-4","article-title":"Hypopituitarism","volume":"369","author":"Schneider","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0430","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2169\/internalmedicine.8446-16","article-title":"Prednisolone-responsive postpartum IgG4-related hypophysitis","volume":"57","author":"Koide","year":"2018","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.jns.2021.117420_bb0435","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00292-016-0164-x","article-title":"Hypophysitis: formen und differenzial diagnose","volume":"37","author":"Saeger","year":"2016","journal-title":"Pathologe"},{"issue":"4","key":"10.1016\/j.jns.2021.117420_bb0445","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12022-010-9128-5","article-title":"Immunohistochemical study for IgG4-positive plasmacytes in pituitary inflammatory lesions","volume":"21","author":"Nishioka","year":"2010","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0450","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.wneu.2016.07.071","article-title":"Clinical interrogation for unveiling an isolated hypophysitis mimicking pituitary adenoma","volume":"99","author":"Lee","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.jns.2021.117420_bb0455","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1507\/endocrj.EJ13-0407","article-title":"Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis","volume":"61","author":"Iseda","year":"2014","journal-title":"Endocr. J."},{"key":"10.1016\/j.jns.2021.117420_bb0460","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2169\/internalmedicine.8446-16","article-title":"Prednisolone-responsive postpartum IgG4-related hypophysitis","volume":"57","author":"Koide","year":"2018","journal-title":"Intern. Med."},{"issue":"28","key":"10.1016\/j.jns.2021.117420_bb0465","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003344","article-title":"Large vessel involvement by IgG4-related disease","volume":"95","author":"Perugino","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jns.2021.117420_bb0470","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/14397595.2018.1546367","article-title":"IgG4-related periaortitis\/periarteritis: an under-recognized condition that is potentially life-threatening","volume":"29","author":"Mizushima","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jns.2021.117420_bb0475","article-title":"IgG4-related: a new etiology underlying diffuse intracranial dilating vasculopathy","volume":"107","author":"Marlin","year":"2017","journal-title":"Word Neurosurg."},{"issue":"8","key":"10.1016\/j.jns.2021.117420_bb0480","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMcpc1613461","article-title":"Case 6-2017. A 57-year-old woman with fatigue, sweats, weight loss, headache, and skin lesions","volume":"376","author":"Monach","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0485","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1440-1789.2011.01227.x","article-title":"Vertebral basilar system dolichoectasia with marked infiltration of IgG4-containing plasma cells: a manifestation of IgG4-related disease?","volume":"32","author":"Toyoshima","year":"2012","journal-title":"Neuropathology."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0490","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.carpath.2015.08.006","article-title":"Carotid aneurism with acute dissection: an unusual case of IgG4-related diseases","volume":"25","author":"Barp","year":"2016","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0495","doi-asserted-by":"crossref","first-page":"401890","DOI":"10.1155\/2012\/401890","article-title":"IgG4-related perineural disease","volume":"2012","author":"Inoue","year":"2012","journal-title":"Int. J. Rheumatol."},{"issue":"5","key":"10.1016\/j.jns.2021.117420_bb0500","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multi-center phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0505","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/tjo.tjo_12_17","article-title":"Immunoglobulin G4-related ophthalmic disease","volume":"8","author":"Yu","year":"2018","journal-title":"Taiwan J. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0510","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/14397595.2014.950036","article-title":"Everyday clinical practice in IgG4-related dacryoadenitis and\/or sialadenitis: results from the SMART database","volume":"25","author":"Yamamoto","year":"2015","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.jns.2021.117420_bb0515","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13075-018-1567-2","article-title":"Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients","volume":"20","author":"Wang","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jns.2021.117420_bb0520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10384-014-0353-1","article-title":"Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids","volume":"59","author":"Yu","year":"2015","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0525","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/bjophthalmol-2015-307164","article-title":"Intraorbital corticosteroid injection for the treatment of IgG4-related ophthalmic disease","volume":"100","author":"Andrew","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2021.117420_bb0530","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/eye.2014.251","article-title":"Rituximab for the treatment of IgG4-related orbital disease: experience from five cases","volume":"29","author":"Wu","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jns.2021.117420_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2021.117420_bb0540","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/rheumatology\/kes358","article-title":"Necessity of early intervention for IgG4-related disease\u2013delayed treatment induces fibrosis progression","volume":"52","author":"Shimizu","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 10","key":"10.1016\/j.jns.2021.117420_bb0545","article-title":"A Trial of XmAb (R) 5871, a reversible inhibitor of CD19+ cells, in IgG4-related disease","volume":"68","author":"Stone","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2021.117420_bb0550","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman\u2019s disease","volume":"22","author":"Sato","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jns.2021.117420_bb0555","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0b013e3182a64fa4","article-title":"Successful \u201cmedical\u201d orbital decompression with adjunctive rituximab for severe visual loss in IgG4-related orbital inflammatory disease with orbital myositis","volume":"30","author":"Chen","year":"2014","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"key":"10.1016\/j.jns.2021.117420_bb0560","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/09273948.2014.928735","article-title":"Adjunctive orbital radiotherapy for ocular adnexal IgG4-related disease: preliminary experience in patients refractory or intolerant to corticosteroid therapy","volume":"23","author":"Lin","year":"2015","journal-title":"Ocul. Immunol. Inflamm."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21001131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:56:33Z","timestamp":1758383793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21001131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":110,"alternative-id":["S0022510X21001131"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117420","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neurology of IGG4-related disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117420"}}